<DOC>
	<DOCNO>NCT00002365</DOCNO>
	<brief_summary>To determine compare safety tolerability 3 dose LXR015-1 HIV-infected patient .</brief_summary>
	<brief_title>A Study LXR015-1 HIV-Infected Patients</brief_title>
	<detailed_description>Patients randomize 1 3 dos oral LXR015-1 28 day patient monitored adverse event duration study . Patients continue monitor least 4 week completion dosing .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients must : Documented HIV infection . CD4 cell count le 200 cells/mm3 . Prior Medication : Allowed : Acute therapy opportunistic infection serious AIDS defining infection must complete least 28 day study entry . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Patients unable take adequate oral intake ( i.e . unable eat 1 meal day chronic nausea , emesis , abdominal/oral/esophageal discomfort ) . Patients severe diarrhea define &gt; = 7 stool per day , acute diarrhea due treatable cause . NOTE : If patient Cryptosporidia , Mycobacterium avium , Cytomegalovirus unresponsive treatment le 7 stool per day , patient may participate study . Patients severe lifethreatening laboratory clinical abnormality , expect live 8 week . Patients active opportunistic infection , include tuberculosis , cryptococcosis , serious AIDS defining infection require immediate treatment . Acute therapy must complete least 28 day study entry . Patients unexplained elevated temperature &gt; = 38.5 degree C persist 7 day within 14 day study entry . Patients malignancy squamous basal carcinoma skin . Patients visceral Kaposi 's sarcoma lymphoma require systemic chemotherapy radiation treatment exclude . Patients Kaposi 's skin mucous membrane may enroll study . Patients , judgment investigator unable comply protocol . Concurrent Treatment : Excluded : Radiation therapy . Patients follow prior condition exclude : A known history hypersensitivity reaction soy protein soy lecithin . NOTE : This hypersensitivity identify medical history , skin testing . Excluded : Systemic chemotherapy . Acute therapy opportunistic infection serious AIDS defining infection . Intravenous rehydration treatment diarrhea . Required : Patient must take stable regimen ( 8 week ) antiviral , antiopportunistic infection and/or antidiarrheal ( patient diarrhea ) medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 1998</verification_date>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>